These fears have been blown grossly out of proportion. There are two defining fear catalysts stunting ACRX's stock price momentum at the moment. Primarily, …
Following U.S. election volatility some analysts have updated their recommended target prices on shares of AcelRx Pharmaceuticals, Inc. (ACRX). According to the most recently released broker notes, 1 analyst has a rating of “strong …
It has underperformed by 18.19% the S&P500. The stock of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is a huge mover today! APG Asset Management N.V. now owns 8,933,153 shares of the basic materials company's stock valued …
Get your Free Trial here. AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) reported key results from the Phase 3 IAP312 study of ZALVISO® (sufentanil sublingual tablet system), an investigational product candidate being developed for the …
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. Its product candidates is …
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)‘s stock had its “hold” rating reaffirmed by research analysts at Cowen …
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having an incredibly strong day in the market today, and for good reason. A Seeking Alpha contributor wrote an article about the company, bringing a massive coming catalyst to light …
If you want a Stock Review on BABY, MASI, SPNC or ACRX then come over to http://dailystocktracker.com/register …
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Friday. According to Zacks, “AcelRx Pharmaceuticals, Inc., is a specialty …
AcelRx has been on the search for a new CFO since June 5, when Timothy Morris resigned. ACRX stock snapped out of a four-month slump on Monday, with the stock gapping higher after Jefferies initiated coverage with a "buy" rating. …